Search

everythinglearnresearchcommunity

for

Search:↓

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Intralesional methotrexate and triamcinolone acetonide are more effective than Vitamin D3 for treating alopecia areata.

Certain hair and scalp features can predict the severity of alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Oral Apremilast effectively treats alopecia areata in most patients.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.